Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Rationale: Low‐dose ketamine is a rapid‐acting antidepressant, to which female rodents are more sensitive as compared to males. However, the mechanism mediating this sex difference in ketamine sensitivity remains elusive. Objectives: We sought to determine whether male and female mice differ in their behavioral sensitivity to low doses of ketamine, and uncover how ovarian hormones influence females’ ketamine sensitivity. We also aimed to uncover some of the molecular mechanism(s) in mood‐related brain regions that mediate sex differences in ketamine antidepressant effects. Methods: Male and female mice (freely‐cycling, diestrus 1 [D1], proestrus [Pro], or D1 treated with an estrogen receptor (ER) &agr;, ER&bgr;, or progesterone receptor (PR) agonist) received ketamine (0, 1.5, or 3 mg/kg, intraperitoneally) and were tested in the forced swim test (FST) 30 min later. Ketamine's influence over synaptic plasticity markers in the prefrontal cortex (PFC) and hippocampus (HPC) of males, D1, and Pro females was quantified by Western blot 1 h post‐treatment. Results: Males, freely cycling females, D1 and Pro females exhibited antidepressant‐like responses to 3 mg/kg ketamine. Pro females were the only group where ketamine exhibited an antidepressant effect at 1.5 mg/kg. D1 females treated with an agonist for ER&agr; or ER&bgr; exhibited an antidepressant‐like response to 1.5 mg/kg ketamine. Ketamine (3 mg/kg) increased synaptic plasticity‐related proteins in the PFC and HPC of males, D1, and Pro females. Yet, Pro females exhibited an increase in p‐Akt and p‐CaMKII&agr; in response to 1.5 and 3 mg/kg ketamine. Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ER&agr; and ER&bgr;, leading to greater activation of synaptic plasticity‐related kinases within the PFC and HPC. HIGHLIGHTSMales and diestrus 1 females exhibited antidepressant‐like responses 3 mg/kg ketamine.Females' ketamine sensitivity was increased by ovarian hormones and by estrogen receptor agonists.Proestrus behavioral ketamine sensitivity was mirrored by increased PFC activation of Akt and of HPC Akt and CaMKII&agr;.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 5×
“Previous reports posited that ketamine's up-regulation of AMPA receptor expression may underlie enhanced glutamatergic sensitivity and synaptic plasticity (Kavalali and Monteggia, 2012; Li et al., 2010).”
BackgroundResultInfluentialEpidemiology of women and depression
Kessler, R. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00426-3 · Cited by 2,006 · cited 2×
“…of some molecular mechanisms of ketamine's rapid effects, the majority of these investigations have been conducted in males; creating a serious gap in our knowledge, since females experience a two-fold increased risk of depression as compared to males (Kessler, 2003; Van de Velde et al., 2010).”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 7×
“Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ERa and ERb, leading to greater activation of synaptic plasticityrelated kinases within the PFC and HPC. © 2017 Elsevier Ltd.”
BackgroundInfluentialMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 1×
“Ketamine rapidly increases glutamate release and neuronal depolarization (H€ oflich et al., 2017; Li et al., 2017; Moghaddam et al., 1997).”
BackgroundGlycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · cited 6×
“Conclusion: Our results indicate that females’ enhanced sensitivity to ketamine during Pro is likely mediated through estradiol acting on ERa and ERb, leading to greater activation of synaptic plasticityrelated kinases within the PFC and HPC. © 2017 Elsevier Ltd.”
BackgroundInfluential
Cited by
Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022489118 · Cited by 378
Muscle metabolism and atrophy: let’s talk about sex
Rosa-Caldwell, M. E., & Greene, N. P. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0257-3 · Cited by 202
“For example, female mice are more sensitive to the effects of antidepressants during proestrus [159, 160] and other pathologies such as autoimmune diseases are thought to be mediated by estrogen and the estrous/menstrual cycle [161, 162], suggesting that hormonal status may influence some disease pathologies.”
BackgroundKruse, J. L., Vasavada, M. M., Olmstead, R., Hellemann, G., Wade, B., Breen, E. C., Brooks, J. O., Congdon, E., Espinoza, R., Narr, K. L., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01268-z · Cited by 48
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Zaytseva, A., Bouckova, E., Wiles, M. J., Wustrau, M. H., Schmidt, I. G., Mendez-Vazquez, H., Khatri, L., & Kim, S. (2023) · eLife · doi:10.7554/elife.86022 · Cited by 48
“86022 8 of 28 test and novelty suppressed feeding test (Carrier and Kabbaj, 2013; Franceschelli et al., 2015; Zanos et al., 2016; Dossat et al., 2018).”
BackgroundWallace, T., & Myers, B. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.737960 · Cited by 8
Metadata
- Authors
- Dossat, A. M., Wright, K. N., Strong, C. E., & Kabbaj, M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 130
- Pages
- 30-41
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2770049007
- Cited by
- 72
- References
- 24
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.11.022
- The paper
- Dossat, A. M., Wright, K. N., Strong, C. E., & Kabbaj, M. (2018). Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.11.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.